跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Insulin, Blood Sugar, and Diabetes: A Systematic Course

1Blood Glucose Homeostasis and the Endocrine Players2Insulin Secretion and the Insulin Receptor3Insulin Signaling and Cellular Glucose Uptake4Type 1 Diabetes: Autoimmune Beta-Cell Destruction5Type 2 Diabetes: Insulin Resistance and Beta-Cell Failure6Clinical Management: Connecting Mechanisms to Treatment
Type 1 Diabetes: Autoimmune Beta-Cell Destruction

When the Beta Cells Are the Target

1 / 2
The key point is that this is a selective attack. Cytotoxic T cells recognize beta-cell antigens and kill those cells, while alpha cells survive. So the body loses the ability to make insulin, but it keeps the ability to make glucagon. That asymmetry is what drives everything that follows. The signaling machinery inside liver, muscle, and fat is still there and still functional, but it is never switched on, because the ligand that would switch it on is no longer secreted.
0:00 / 0:00

A selective immune attack

Beta cells carry antigens that the immune system mistakenly treats as foreign. Antigen-presenting cells activate autoreactive CD4+ T cells, which help CD8+ cytotoxic T cells recognize beta-cell peptides on MHC class I and kill the cells. Cytokines such as interferon-gamma, tumor necrosis factor, and interleukin-1 amplify the damage and impair surviving beta cells. Alpha cells and other islet cells are largely spared, so the loss is specific to insulin secretion.

Absolute, not relative, deficiency

The defect is loss of insulin production, not loss of insulin responsiveness. The receptor, IRS, PI3K/Akt cascade, AS160, and GLUT4 machinery you studied earlier remain structurally intact, but they are never activated because the ligand is absent. No amount of target-cell sensitivity can compensate for a hormone that is not secreted.

Glucagon without a counterweight

Alpha cells keep secreting glucagon. Normally insulin restrains glucagon release and opposes its hepatic effects; with insulin gone, glucagon signaling is unopposed. The fed-state switch that insulin normally throws is stuck in the fasted position, so the liver behaves as though the body is starving even when glucose is abundant in the blood.

Why symptoms appear late

Beta-cell loss is gradual. Clinical hyperglycemia usually appears only after a large fraction of beta-cell mass has been destroyed, which is why the disease can be immunologically active for years before it is diagnosed.

参考资料

  1. [1]Type 1 Diabetes — National Institute of Diabetes and Digestive and Kidney Diseasesniddk.nih.gov
  2. [2]Type 1 diabetes — World Health Organizationwho.int
上一页1 / 2下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion